Todd Richmond

Thrombolex, Inc. focuses on developing interventional catheter-based therapies for the treatment of acute venous thromboembolic medical disorders (VTE). The company is headquartered in Doylestown, PA.

Thrombolex, Inc. focuses on developing interventional catheter-based therapies for the treatment of acute venous thromboembolic medical disorders (VTE). The company is headquartered in Doylestown, PA.

Thrombolex, Inc. focuses on developing interventional catheter-based therapies for the treatment of acute venous thromboembolic medical disorders (VTE). The company is headquartered in Doylestown, PA.

Thrombolex, Inc. focuses on developing interventional catheter-based therapies for the treatment of acute venous thromboembolic medical disorders (VTE). The company is headquartered in Doylestown, PA.

Part of D.O.R.C. Dutch Ophthalmic Research Center (International) BV, Peregrine Surgical LLC is a manufacturer, packager, and developer of single-use devices used for ophthalmic surgery. The company is based in New Britain, PA. Peregrine Surgical has served the ophthalmic community as a private label manufacturer for reusable and disposable products routinely used in both anterior and posterior segment surgeries. Peregrine Surgical has launched many effective products, including re-sposable forceps, illuminated endo-laser probes, flexible membrane scrapers, and illuminated picks. Peregrine Surgical continues to provide services to the largest surgical supply companies in the world with products that deliver high standards of quality and reliability. The company was founded in 1991 by Sheila Richmond, John Richmond, and Todd Richmond has been the CEO of the company since 1997. Peregrine Surgical was acquired by D.O.R.C. Dutch Ophthalmic Research Center (International) BV on October 14, 2022.